Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vesna Grivcheva-Panovska

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2020
Hereditary Angioedema Attack in Utero and Treatment of the Mother and FetusVesna Grivcheva-Panovska, Bruno Giannetti
Allergy and Asthma Proceedings|January 5, 2022
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema managementVesna Grivcheva-Panovska, Timothy J Craig, Hilary Longhurst, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 18, 2019
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in childrenAvner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, et al.
Clinical Reviews in Allergy & Immunology|November 7, 2024
Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic ReviewHilary J Longhurst, Mauro Cancian, Vesna Grivcheva-Panovska, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2009
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksTimothy J Craig, Robyn J Levy, Richard L Wasserman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacksJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
Allergy and Asthma Proceedings|January 26, 2011
Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensityJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 21, 2020
Hereditary Angioedema Attack in Utero and Treatment of the Mother and FetusVesna Grivcheva-Panovska, Bruno Giannetti
Allergy and Asthma Proceedings|January 5, 2022
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema managementVesna Grivcheva-Panovska, Timothy J Craig, Hilary Longhurst, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 18, 2019
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in childrenAvner Reshef, Vesna Grivcheva-Panovska, Aharon Kessel, et al.
Clinical Reviews in Allergy & Immunology|November 7, 2024
Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic ReviewHilary J Longhurst, Mauro Cancian, Vesna Grivcheva-Panovska, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2009
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksTimothy J Craig, Robyn J Levy, Richard L Wasserman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacksJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
Allergy and Asthma Proceedings|January 26, 2011
Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensityJonathan A Bernstein, Bruce Ritchie, Robyn J Levy, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Pageof 3